BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21483701)

  • 1. Potential impact of antiretroviral therapy and screening on cervical cancer mortality in HIV-positive women in sub-Saharan Africa: a simulation.
    Atashili J; Smith JS; Adimora AA; Eron J; Miller WC; Myers E
    PLoS One; 2011 Apr; 6(4):e18527. PubMed ID: 21483701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating Cervical Cancer Screening with HIV Care in Cameroon: Comparative Risk Analysis of Cervical Disease in HIV-Infected Women Receiving Antiretroviral Therapy to Women in the General Population.
    Bekolo CE; O'Bryan G; Tchago FE; Nangue C; Bekoule PS; Kollo B
    PLoS One; 2016; 11(2):e0149152. PubMed ID: 26866371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women.
    Ahdieh-Grant L; Li R; Levine AM; Massad LS; Strickler HD; Minkoff H; Moxley M; Palefsky J; Sacks H; Burk RD; Gange SJ
    J Natl Cancer Inst; 2004 Jul; 96(14):1070-6. PubMed ID: 15265968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV-positive women.
    Heard I; Potard V; Costagliola D
    Antivir Ther; 2006; 11(8):1091-6. PubMed ID: 17302379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of HAART on HPV-related cervical disease.
    Adler DH
    Curr HIV Res; 2010 Oct; 8(7):493-7. PubMed ID: 20946095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents.
    Shrestha S; Sudenga SL; Smith JS; Bachmann LH; Wilson CM; Kempf MC
    BMC Infect Dis; 2010 Oct; 10():295. PubMed ID: 20946655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly active antiretroviral therapy (HAART) and outcome of cervical lesions and high-risk HPV in women living with HIV (WLHIV): A systematic review and meta-analysis.
    Gupta R; Mariano LC; Singh S; Gupta S
    Eur J Obstet Gynecol Reprod Biol; 2022 Nov; 278():153-158. PubMed ID: 36194939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
    Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG
    Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between Highly Active Antiretroviral Therapy (HAART) and human papillomavirus type 16 (HPV 16) infection among women in Sub-Saharan Africa and public health implications: A systematic review.
    Menon S; Rossi R; Kariisa M; Acharya SD; Zdraveska N; Mahmood S; Callens S; Ndizeye Z
    PLoS One; 2019; 14(3):e0213086. PubMed ID: 30856196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical screening in HIV-positive women: characteristics of those who default and attitudes towards screening.
    Shah S; Montgomery H; Smith C; Madge S; Walker P; Evans H; Johnson M; Sabin C
    HIV Med; 2006 Jan; 7(1):46-52. PubMed ID: 16313292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AIDS malignancies in the era of highly active antiretroviral therapy.
    Gates AE; Kaplan LD
    Oncology (Williston Park); 2002 May; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and management of precancerous lesions to prevent cervical cancer in low-resource settings.
    Sellors J; Lewis K; Kidula N; Muhombe K; Tsu V; Herdman C
    Asian Pac J Cancer Prev; 2003; 4(3):277-80. PubMed ID: 14507251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency virus-positive women.
    Minkoff H; Zhong Y; Burk RD; Palefsky JM; Xue X; Watts DH; Levine AM; Wright RL; Colie C; D'Souza G; Massad LS; Strickler HD
    J Infect Dis; 2010 Mar; 201(5):681-90. PubMed ID: 20105077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa.
    Mosam A; Shaik F; Uldrick TS; Esterhuizen T; Friedland GH; Scadden DT; Aboobaker J; Coovadia HM
    J Acquir Immune Defic Syndr; 2012 Jun; 60(2):150-7. PubMed ID: 22395672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women.
    Estrella MM; Parekh RS; Abraham A; Astor BC; Szczech LA; Anastos K; Dehovitz JA; Merenstein DJ; Pearce CL; Tien PC; Cohen MH; Gange SJ
    J Acquir Immune Defic Syndr; 2010 Oct; 55(2):217-20. PubMed ID: 20581688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical neoplasia and the HIV-infected patient.
    Stier E
    Hematol Oncol Clin North Am; 2003 Jun; 17(3):873-87. PubMed ID: 12852660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical Cancer Screening among Women Receiving Antiretroviral Therapy in a Resource-Limited Environment.
    New-Aaron M; Meza JL; Goedert MH; Kibusi SM; Mkhoi ML; Mayengo CD; Charles J; Shabani S; Musil KM; Cheney A; Sumba S
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):2035-2045. PubMed ID: 32711430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical cancer screening of women living with HIV infection: a must in the era of antiretroviral therapy.
    Franceschi S; Jaffe H
    Clin Infect Dis; 2007 Aug; 45(4):510-3. PubMed ID: 17638204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, Predictors, and Same Day Treatment of Positive VIA Enhanced by Digital Cervicography and Histopathology Results in a Cervical Cancer Prevention Program in Cameroon.
    DeGregorio GA; Bradford LS; Manga S; Tih PM; Wamai R; Ogembo R; Sando Z; Liu Y; Schwaiger C; Rao SR; Kalmakis K; Kennedy Sheldon L; Nulah K; Welty E; Welty T; Ogembo JG
    PLoS One; 2016; 11(6):e0157319. PubMed ID: 27280882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of antiretroviral therapy on the incidence of cervical neoplasia among HIV-infected women: a population-based cohort study in Taiwan.
    Chen YC; Li CY; Liu HY; Lee NY; Ko WC; Ko NY
    AIDS; 2014 Mar; 28(5):709-15. PubMed ID: 24326354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.